Candriam S.C.A. - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Candriam S.C.A. ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,712,000
-4.0%
362,319
-0.0%
0.01%0.0%
Q4 2020$1,783,000
-68.3%
362,346
+54.9%
0.01%
-73.6%
Q3 2020$5,627,000
+10.9%
233,850
+78.8%
0.05%
-1.9%
Q2 2020$5,073,000130,7890.05%
Other shareholders
APREA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders